ALPS Medical Breakthroughs ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.50
資產淨值: 55.60
成立日期: 30/12/2014
 
分析
市值分佈:
45.99%
大市值
39.99%
中市值
14.71%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 11/11/2026 04:01) 總持有投資項目: 102  
0%
 
100%
     10大 (31.85%)
代號 名稱 佔比% ▼ 持有日期
ORKAOruka Therapeutics Inc4.2730/10/2026
CGONCG Oncology3.9430/09/2026
MANEVeradermics Inc3.8830/10/2026
DFTXDefinium Therapeutics Inc3.2530/10/2026
TVTXTravere Therapeutics3.1630/10/2026
DNTHDianthus Therapeutics3.0830/09/2026
EWTXEdgewise Therapeutics2.8130/10/2026
RLAYRelay Therapeutics2.6830/10/2026
AMLXAmylyx Pharmaceuticals2.4130/10/2026
ACADACADIA Pharmaceuticals2.3630/10/2026
XENEXenon Pharmaceuticals2.2630/09/2026
TARSTarsus Pharmaceuticals2.1930/10/2026
DYNDyne Therapeutics2.0730/10/2026
IRONDisc Medicine2.0730/10/2026
IDYAIDEAYA Biosciences2.0530/10/2026
DNLIDenali Therapeutics2.0230/10/2026
VRDNViridian Therapeutics1.8630/10/2026
MBXMBX Biosciences Inc.1.7930/10/2026
ZLABZai Lab Limited1.6530/10/2026
NAMSNewAmsterdam Pharma Company NV1.6030/10/2026
 1    2    3    4    5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.